| Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma R Motzer, B Alekseev, SY Rha, C Porta, M Eto, T Powles, V Grünwald, ... New England Journal of Medicine 384 (14), 1289-1300, 2021 | 1198 | 2021 |
| Darolutamide and survival in metastatic, hormone-sensitive prostate cancer MR Smith, M Hussain, F Saad, K Fizazi, CN Sternberg, ED Crawford, ... New England Journal of Medicine 386 (12), 1132-1142, 2022 | 484 | 2022 |
| Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial T Powles, M Kockx, A Rodriguez-Vida, I Duran, SJ Crabb, ... Nature medicine 25 (11), 1706-1714, 2019 | 472 | 2019 |
| Re: PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients with Metastatic Castration-resistant Prostate Cancer E Castro, N Romero-Laorden, A Del Pozo J. Clin. Oncol. 37, 490-503, 2019 | 319 | 2019 |
| Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution … V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ... Annals of Oncology 28 (7), 1508-1516, 2017 | 264 | 2017 |
| Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial MR Smith, HI Scher, S Sandhu, E Efstathiou, PN Lara, YY Evan, ... The Lancet Oncology 23 (3), 362-373, 2022 | 122 | 2022 |
| Atherosclerosis and thrombosis: lessons from animal models L Badimon Thrombosis and Haemostasis 86 (07), 356-365, 2001 | 113 | 2001 |
| A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS). T Powles, A Rodriguez-Vida, I Duran, SJ Crabb, MS Van Der Heijden, ... Journal of Clinical Oncology 36 (15_suppl), 4506-4506, 2018 | 100 | 2018 |
| Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. PC Ramos, MJ Mendez, PR Ames, MA Khamashta, GR Hughes Clinical and experimental rheumatology 14 (3), 295-299, 1996 | 91 | 1996 |
| Real-world clinical experience with idebenone in the treatment of Leber hereditary optic neuropathy CB Catarino, B von Livonius, C Priglinger, R Banik, S Matloob, ... Journal of Neuro-Ophthalmology 40 (4), 558-565, 2020 | 89 | 2020 |
| Plasma androgen receptor and docetaxel for metastatic castration-resistant prostate cancer V Conteduca, A Jayaram, N Romero-Laorden, D Wetterskog, S Salvi, ... European urology 75 (3), 368-373, 2019 | 77 | 2019 |
| Valoración de la capacidad funcional después de un ingreso hospitalario en pacientes nonagenarios F Formiga, X Jacob, M Vidal, AL pez Soto, E Sacanella, F Masanés Medicina clínica 115 (18), 695-696, 2000 | 76 | 2000 |
| Fecal immunochemical test accuracy in average-risk colorectal cancer screening V Hernandez, J Cubiella, MC Gonzalez-Mao, F Iglesias, C Rivera, ... World journal of gastroenterology: WJG 20 (4), 1038, 2014 | 74 | 2014 |
| Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder B Szabados, M Kockx, ZJ Assaf, PJ van Dam, A Rodriguez-Vida, I Duran, ... European urology 82 (2), 212-222, 2022 | 69 | 2022 |
| A point mutation in the RDS-peripherin gene in a Spanish family with central areolar choroidal dystrophy C Reig, A Serra, E Gean, M Vidal, J Arumi, MD De la Calzada, J Antich, ... Ophthalmic genetics 16 (2), 39-44, 1995 | 60 | 1995 |
| Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and … E Aranda, JL Manzano, F Rivera, M Galán, M Valladares-Ayerbes, ... Annals of oncology 23 (7), 1919-1925, 2012 | 57 | 2012 |
| A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). T Powles, JMG Larkin, P Patel, B Pérez-Valderrama, A Rodriguez-Vida, ... Journal of Clinical Oncology 37 (7_suppl), 545-545, 2019 | 55 | 2019 |
| Atención temprana M Vidal, J Díaz Guía Práctica para la estimulación del niño de 0 a 3, 1990 | 54 | 1990 |
| Variaciones fisiológicas normales del desarrollo puberal: edad del inicio puberal, edad de la menarquia y talla MM Hernández, R Benítez, I Medranda, C Pizarro, MJ Méndez Anales de Pediatría 69 (2), 147-153, 2008 | 53 | 2008 |
| Guillain-Barré-Strohl syndrome and COVID-19: case report and literature review L Diez-Porras, E Vergés, F Gil, MJ Vidal, J Massons, A Arboix Neuromuscular Disorders 30 (10), 859-861, 2020 | 52 | 2020 |
